Jing Yao

Jing Yao

Auto-generated profile, based on publicly available information

Jing Yao

State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Druggability of Biopharmaceuticals Department of Pharmaceutics China Pharmaceutical University 639 Longmian Avenue Nanjing 211198 P. R. China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 April 2019 in Journal of Neurotrauma
Verified
Journal Article
Closed access
DYDian-Xu Yang
Dian-Xu Yang
YJYao Jing
Yao Jing
YLYing-Liang Liu
Ying-Liang Liu
ZXZhi-Ming Xu
Zhi-Ming Xu
FYFang Yuan
Fang Yuan
Hengli TianHengli Tian
Hengli Tian
Transient receptor potential vanilloid 1 (TRPV1) is widely expressed in the central nervous system and is activated by various stimuli. Inhibiting TRPV1 has neuroprotective effects in cerebral ischemia. However, the role of inhibiting TRPV1 to maintain blood–brain barrier (BBB) integrity following traumatic brain injury (TBI) remains unclear. Therefore, we investigated the effects of capsazepine-mediated TRPV1 inhibition on the BBB in a mouse model of TBI. Adult male C57BL/6 mice were subjected to controlled cortical impact injury and received capsazepine (1 µmol/kg body weight, twice daily, intraperitoneally) until sacrifice. Further, mouse brain microvascular endothelial (bEnd.3) cells were cultured and subjected to biaxial stretch injury to investigate the mechanisms underlying the protective effects of capsazepine. TRPV1 expression was upregulated in the peri-contusional area following TBI, peaking at 24 h post-TBI. Capsazepine-treated mice demonstrated decreased brain edema (p = 0.010), Evans Blue extravasation (p = 0.001), tissue hemoglobin levels (p = 0.002), and loss of tight junction proteins (p = 0.016 ZO-1 expression; p = 0.013 occludin expression) after TBI compared with the vehicle-treated group. Capsazepine significantly alleviated early-stage apoptosis by attenuating activation of JNK, P38, and caspase-3, resulting in a protective effect on the level of ZO-1 in bEnd.3 cells after stretch injury. We conclude that the expression of TRPV1 is upregulated following TBI, and inhibition of TRPV1 attenuated disruption of the BBB in a mouse model of TBI, at least partly, through its anti-apoptotic effects on brain endothelial cells. Blocking TRPV1 may be a promising pharmacotherapeutic intervention to protect against BBB disruption after TBI.

26 June 2022 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
HXHui Xiong
Hui Xiong
XLXiaoyan Liu
Xiaoyan Liu
ZXZuohan Xie
Zuohan Xie
LZLinyuan Zhu
Linyuan Zhu
HLHaipeng Lu
Haipeng Lu
JYJing Yao
Jing Yao